Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Felsenberg

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
International Journal of Sports Medicine|September 7, 2002
Oxygen uptake in whole-body vibration exercise: influence of vibration frequency, amplitude, and external loadJ Rittweger, J Ehrig, K Just, et al.
International Journal of Clinical Pharmacology Research|July 1, 2004
Pharmacoeconomic analysis of osteoporosis treatment with risedronateJ G Brecht, H P Kruse, D Felsenberg, et al.
Der Unfallchirurg|October 16, 2015
[New strategies for exercise training in osteoporosis]A Winkelmann, S Schilling, C Neuerburg, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 2, 1998
[Morphometric analysis of roentgen images of the spine for diagnosis of osteoporosis-induced fracture]D Felsenberg, E Wieland, W Gowin, et al.
European Journal of Radiology|July 1, 1995
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCTW A Kalender, D Felsenberg, H K Genant, et al.
Contraception|February 19, 2004
A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral densityJ Endrikat, E Mih, B Düsterberg, et al.
Bone|August 30, 2005
Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosisD Felsenberg, P Miller, G Armbrecht, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2011
Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound studyL Ferrar, C Roux, D M Reid, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 5, 2013
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosisP Hadji, D Felsenberg, M Amling, et al.
Bone|April 29, 2006
Relationship between risk factors and QUS in a European Population: The OPUS studyA Stewart, D Felsenberg, R Eastell, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
International Journal of Sports Medicine|September 7, 2002
Oxygen uptake in whole-body vibration exercise: influence of vibration frequency, amplitude, and external loadJ Rittweger, J Ehrig, K Just, et al.
International Journal of Clinical Pharmacology Research|July 1, 2004
Pharmacoeconomic analysis of osteoporosis treatment with risedronateJ G Brecht, H P Kruse, D Felsenberg, et al.
Der Unfallchirurg|October 16, 2015
[New strategies for exercise training in osteoporosis]A Winkelmann, S Schilling, C Neuerburg, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 2, 1998
[Morphometric analysis of roentgen images of the spine for diagnosis of osteoporosis-induced fracture]D Felsenberg, E Wieland, W Gowin, et al.
European Journal of Radiology|July 1, 1995
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCTW A Kalender, D Felsenberg, H K Genant, et al.
Contraception|February 19, 2004
A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral densityJ Endrikat, E Mih, B Düsterberg, et al.
Bone|August 30, 2005
Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosisD Felsenberg, P Miller, G Armbrecht, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2011
Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound studyL Ferrar, C Roux, D M Reid, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 5, 2013
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosisP Hadji, D Felsenberg, M Amling, et al.
Bone|April 29, 2006
Relationship between risk factors and QUS in a European Population: The OPUS studyA Stewart, D Felsenberg, R Eastell, et al.
Pageof 19